Financials
| | | Annual |
| 2006 | 2007 | 2008 |
| Income Statement | | | |
| Revenue | - | - | - |
| Operation Income | - | - | - |
| Net Income | - | - | - |
| Basic EPS | - | - | - |
| Avg. Diluted Shares Outstanding | - | - | - |
| Balance Sheet | | | |
| Current Assets | - | - | - |
| Non Current Assets | - | - | - |
| Total Assets | - | - | - |
| Current Liabilities | - | - | - |
| Total Liabilities | - | - | - |
| Shareholder Equity | - | - | - |
| Cash Flow | | | |
| Cash From Operations | - | - | - |
| Capital Expenditure | - | - | - |
| Free Cash Flow | - | - | - |
In millions, except "Basic EPS".
Currency is .
Company Profile
Wyeth Limited operates through two business segments: pharmaceuticals and Others. Pharmaceuticals segment comprise of Formulations. Pharmaceuticals segment comprise of Formulations and Others comprise of over-the-counter (OTC) pharmaceuticals & cosmetics.
Sector
Health Care
Industry
Diagnostic Substances
Stock Style
Small-Blend
Fiscal Year Ends
March
Employees
-
Key Stats
Price/Earning TTM-
Price/Book-
Price/Sales TTM-
Rev Growth (3 year avg)-
EPS Growth (3 year avg)-
Operating Margin % TTM-
Net Margin % TTM-
ROE TTM-
Debt/Equity-
Dividends
| Previous | Latest |
|---|
| Declared Date | 25/06/09 | 22/02/10 |
| Ex-Div | 10/08/09 | 06/04/10 |
| Paid | 03/09/09 | 22/04/10 |
| Amnt | 32.50 | 20.00 |
